Apoptosis modulating nanochemotherapeutics in the treatment of cancer: Recent progress and advances

作者: Sukhbir Singh , Neelam Sharma , Anil Bansal , Neha Kanojia , Sheshank Sethi

DOI: 10.1016/B978-0-12-815762-6.00006-8

关键词: CancerApoptosisProgrammed cell deathTissue homeostasisCancer researchDrug deliveryPharmaceutical sciencesMedicine

摘要: Abstract Since its recognition as a physiological induction of cell retention well tissue homeostasis, programmed death concepts have attracted significant attention central regulators pathologic disorders. In general, the potential to endure apoptosis was considered an essential attribute cancerous cells and will, therefore, be portrayed trademark tumors. With this chapter, we are indeed attempting produce comprehensive description different targeted anticancer therapy strategies that relevant in recent view pharmaceutical research for medicinal uses. attempt has been made explain existing newly developed drugs, clinically routes administration targeting tumors approved polymers drug delivery systems. Various modulating nano-chemotherapeutics, i.e., colloidal systems such vesicular, particulate, micelles, emulsions, cellular carriers, their progress advances treatment tumor briefly described.

参考文章(138)
David E. Gerber, Targeted therapies: a new generation of cancer treatments. American Family Physician. ,vol. 77, pp. 311- 319 ,(2008)
Goldie Kaul, Mansoor Amiji, Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharmaceutical Research. ,vol. 19, pp. 1061- 1067 ,(2002) , 10.1023/A:1016486910719
Jaime Feliu Batlle, Enrique Espinosa Arranz, Javier de Castro Carpeño, Enrique Casado Sáez, Pilar Zamora Auñón, Andrés Redondo Sánchez, Manuel González Barón, Oral chemotherapy: potential benefits and limitations Clinical & Translational Oncology. ,vol. 6, pp. 335- 340 ,(2004) , 10.1007/BF02710062
XD Duan, CJ Ji, L Nie, Formulation and Development of Dendrimer-Based Transdermal Patches of Meloxicam for the Management of Arthritis Tropical Journal of Pharmaceutical Research. ,vol. 14, pp. 583- 590 ,(2015) , 10.4314/TJPR.V14I4.4
Yoram Reiter, Recombinant immunotoxins in targeted cancer cell therapy Advances in Cancer Research. ,vol. 81, pp. 93- 124 ,(2001) , 10.1016/S0065-230X(01)81003-4
M.J. Osborn, F.M. Huennekens, Enzymatic Reduction of Dihydrofolic Acid Journal of Biological Chemistry. ,vol. 233, pp. 969- 974 ,(1958) , 10.1016/S0021-9258(18)64688-5
Ibrahim H Sahin, Jim Klostergaard, CD44 as a drug delivery target in human cancers: where are we now? Expert Opinion on Therapeutic Targets. ,vol. 19, pp. 1587- 1591 ,(2015) , 10.1517/14728222.2015.1088834
Samira Khani, Fariborz Keyhanfar, Amir Amani, Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Delivery. ,vol. 23, pp. 2035- 2043 ,(2016) , 10.3109/10717544.2015.1088597
QUINTEN P. RUHE, ELIZABETH L. HEDBERG, NESTOR TORIO PADRON, PAUL H.M. SPAUWEN, JOHN A. JANSEN, ANTONIOS G. MIKOS, rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. Journal of Bone and Joint Surgery, American Volume. ,vol. 85, pp. 75- 81 ,(2003) , 10.2106/00004623-200300003-00013